Strategy Signal isthe leading provider of fundamental quantitative analyses of next-generation biotechnology companies. The Strategy Signal Quantitative Library and Models are used for interrogating and exploring relationships among variables to forecast future performance of biotech companies and stocks. Strategy Signal provides proprietary fundamental research to biopharma investors focused on efficiency, near-term alpha and timeliness.
The first rules-based methodology for evaluating biotech fundamentals
Understand the critical components driving biotech value creation in minutes – not weeks, months
Strategy Signal’s proprietary models provide a rational basis for comparing biotechs
Standardized approach examines 90 criteria across 10 critical factors in the 3 key categories that determine value